FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sanofi-Aventis U.S. Enoxaparin Sodium Recall

Enoxaparin Sodium, Injection 120 mg/0

Sanofi-Aventis U.S. LLC · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Jan 17, 2018
Recall ID
D-0153-2018
Check your lot numberHow we source this data

Summary

Sanofi-Aventis U.S. recalled Enoxaparin Sodium starting Dec 5, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0153-2018 on Jan 17, 2018. Reason: Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL. Status: Terminated.

Why it was recalled

Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL

Product description

Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10

Lot numbers, UPCs & expiration codes

Lot #: 7S572, Exp. 04/2019

Where it was sold

Distributed nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0153-2018
Classification
Class III
Status
Terminated
Recall initiated
Dec 5, 2017
FDA report date
Jan 17, 2018
Quantity
11,474 cartons of 10 syringes per carton
Recall type
Voluntary: Firm initiated
Recalling firm
Sanofi-Aventis U.S. LLC

Original FDA data

Every field from FDA enforcement report D-0153-2018, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
78637
Address
55 Corporate Dr
Code information
Lot #: 7S572, Exp. 04/2019
Postal code
08807-1265
Report date
Jan 17, 2018
Product type
Drugs
Recall number
D-0153-2018
Classification
Class III
Recalling firm
Sanofi-Aventis U.S. LLC
Product quantity
11,474 cartons of 10 syringes per carton
Termination date
Oct 11, 2019
Reason for recall
Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL
Voluntary / mandated
Voluntary: Firm initiated
Product description
Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10
Distribution pattern
Distributed nationwide.
Recall initiation date
Dec 5, 2017
Initial firm notification
Letter
Center classification date
Jan 5, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0153-2018, published Jan 17, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls